Average Co-Inventor Count = 6.09
ph-index = 43
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Neotract, Inc. (56 from 68 patents)
2. Medtronic Vascular, Inc. (13 from 965 patents)
3. Acclarent, Inc. (10 from 344 patents)
4. Teleflex Life Sciences Pte. Ltd. (9 from 109 patents)
5. Transvascular, Inc. (3 from 35 patents)
6. Scimed Life Systems, Inc. (2 from 1,831 patents)
7. Exploramed Development, LLC (1 from 1 patent)
94 patents:
1. 12376842 - Flexible system for delivering an anchor
2. 12324576 - Flexible system for delivering an anchor
3. 12201283 - Devices, systems and methods for treating benign prostatic hyperplasia and other conditions
4. 12121228 - Expandable tissue engagement apparatus and method
5. 12042372 - Devices, systems and methods for treating benign prostatic hyperplasia and other conditions
6. 11850140 - Devices, systems and methods for treating benign prostatic hyperplasia and other conditions
7. 11672520 - Expandable tissue engagement apparatus and method
8. 11471148 - Devices, systems and methods for treating benign prostatic hyperplasia and other conditions
9. 11331093 - Flexible system for delivering an anchor
10. 11304793 - Methods, systems and devices for treatment of cerebrospinal venous insufficiency and multiple sclerosis
11. 11090036 - Devices, systems and methods for treating benign prostatic hyperplasia and other conditions
12. 10945719 - Devices, systems and methods for retracting, lifting, compressing, supporting or repositioning tissues or anatomical structures
13. 10925587 - Anchor delivery system
14. 10912637 - Devices, systems and methods for treating benign prostatic hyperplasia and other conditions
15. 10575844 - Devices, systems and methods for treating benign prostatic hyperplasia and other conditions